GlucoMe said last week it inked a pilot collaboration deal with Merck (NYSE:MRK) looking to evaluate GlucoMe’s digital diabetes platform at several hospitals in Vietnam.
Israel-based GlucoMe said that the project was scheduled to begin this month, and that it will compare GlucoMe’s digital diabetes care system against the current standard of care in the country.
Read the whole story on our sister site, Drug Delivery Business News
The post GlucoMe, Merck ink Vietnamese diabetes study deal appeared first on MassDevice.
from MassDevice https://ift.tt/2wjROBJ
Cap comentari:
Publica un comentari a l'entrada